James W. Newman Jr. - Director, Adial Pharmaceuticals, Inc

As of February 25, 2022


What is James W. Newman Jr.'s Net Worth?

The current estimated net worth of Adial Pharmaceuticals, Inc's Director, James W. Newman Jr., is estimated to be about $22.04K . James W. Newman Jr. owns about 49,865 units of Adial Pharmaceuticals, Inc common stock. In the last 4 years at Adial Pharmaceuticals, Inc, James W. Newman Jr. has sold an estimated value of $0 worth.

What is James W. Newman Jr.'s Past Insider Trading?

James W. Newman Jr.'s largest purchase order was 19,644 units , worth over $26.77K on March 30, 2020. In total, James W. Newman Jr. has made about 6 transactions over 4 years of their time at Adial Pharmaceuticals, Inc. James W. Newman Jr. usually trades in March, with the busiest year in 2020 and 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James W. Newman Jr.'s' Mailing Address?

  • Mailing address is 1180 Seminole Trail, Suite 495 Charlottesville VA 22901 VA

What are Adial Pharmaceuticals, Inc's Past Insider Trades?

Adial Pharmaceuticals, Inc's most recent insider trade came on January 3, 2022 by James W. Newman who bought 25,000 units worth $67.3K . In the last 3 years, insiders at Adial Pharmaceuticals, Inc have sold an estimated value of $948.5K and bought an estimated value of $518.17K worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Bankole A Johnson, Chief Medical Officer,  James W. Newman Jr., Director,  and William B. Stilley III, Chief Executive Officer .

ADIAL PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1